Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trehalose 3% Ophthalmic Solution for Dry Eye Disease
NCT06655441Phase 4Recruiting
- Sponsor
- Marshall B. Ketchum University
- Start
- Mar 2026
- Primary completion
- Dec 2026
- Modality
- Drug Delivery Systems, DNA Intercalators/Alkylators, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of trehalose in dry eye disease (DED), sponsored by Marshall B. Ketchum University. Started Mar 2026; status: recruiting.
02
Drugs
trehalose
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06655441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06655441.